Diabetes Nutrition Education for American Indian and Alaska Native Communities
Test of a Culturally Tailored Diabetes Nutrition Education Program for Tribal and Urban American Indian and Alaska Native (AIAN) Communities
1 other identifier
interventional
150
1 country
3
Brief Summary
This study involves pilot testing a newly developed diabetes nutrition education program for American Indian and Alaska Native adults with T2D. The first phase of this study (COMIRB Protocol 18-006) included a qualitative needs assessment to inform the development of this program. The Study Aims include: piloting the newly adapted program at 6 AI/AN collaborating sites to gain feedback on satisfaction, likability, usability and clinical outcomes such as HgA1C (measure of blood sugar control), blood pressure, and body mass index (BMI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes
Started Feb 2020
Typical duration for not_applicable type-2-diabetes
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedStudy Start
First participant enrolled
February 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedJanuary 11, 2022
January 1, 2022
1.9 years
January 28, 2020
January 6, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
Evaluate diabetes nutrition education program impact on HgA1C
Participants will have 2 A1C checks for Immediate intervention and 3 for wait list control. Immediate will have A1C tested at baseline and after the 5th class (at 3 months from baseline). Wait list will have A1C checked baseline, immediately before class #1 (3 months after baseline) and after class #5 (6 months after baseline). A1C will be checked per standard of care at the clinical site
3 months for immediate intervention group 6 months for wait list control group
Evaluate diabetes nutrition education program impact on blood pressure
Participants will have 3 BP checks for Immediate intervention and 5 for wait list control. Immediate will have BP tested at baseline, after the 4th class, and after the 5th class (at 3 months from baseline). Wait list will have BP checked baseline, immediately before class #1 (3 months after baseline), 1 month after baseline, after class #4, and after class #5 (6 months after baseline). Blood pressure will be checked per standard of care at the clinical site.
3 months for immediate intervention group 6 months for wait list control group
Evaluate diabetes nutrition education program impact on weight
Participants will have 3 weight checks for Immediate intervention and 5 for wait list control. Immediate will have weight tested at baseline, after the 4th class, and after the 5th class (at 3 months from baseline). Wait list will have weight checked baseline, at one month of wait list, immediately before class #1 (3 months after baseline), after class #4, and after class #5 (6 months after baseline). Weight will be checked per standard of care at the clinical site.
3 months for immediate intervention group 6 months for wait list control group
Evaluate diabetes nutrition education program impact on eating behavior
Participants will take a self-reported survey measuring their dietary habits using a food frequency table at several timepoints. Immediate intervention participants will take the survey 3 times (baseline, after class 4, after class 5). Wait list control participants will take the survey 5 times (baseline, at 1 month after baseline wait list, immediately before class #1, after class #4, after class #5)
3 months for immediate intervention group 6 months for wait list control group
Evaluate diabetes nutrition education program impact on nutrition knowledge
Participants will take a self-reported survey measuring their nutrition knowledge using a food frequency table at several timepoints. Immediate intervention participants will take the survey 3 times (baseline, after class 4, after class 5). Wait list control participants will take the survey 5 times (baseline, at 1 month after baseline wait list, immediately before class #1, after class #4, after class #5)
3 months for immediate intervention group 6 months for wait list control group
Evaluate diabetes nutrition education program impact on self efficacy for healthful eating
Participants will take a self-reported survey measuring their self efficacy for healthy eating using a food frequency table at several timepoints. Immediate intervention participants will take the survey 3 times (baseline, after class 4, after class 5). Wait list control participants will take the survey 5 times (baseline, at 1 month after baseline wait list, immediately before class #1, after class #4, after class #5)
3 months for immediate intervention group 6 months for wait list control group
Study Arms (2)
Immediate Intervention
EXPERIMENTALParticipants receive diabetes nutrition education classes immediately.
Wait list intervention
EXPERIMENTALParticipants wait listed (control) for 3 months and then receive the diabetes nutrition education classes.
Interventions
Participants will engage in 5 \~90 minute diabetes nutrition education classes. They will learn about healthy eating for type 2 diabetes management. Classes include didactic lesson, hands on learning activity, sharing session, mindful nutrition practice, and physical activity
Eligibility Criteria
You may qualify if:
- AI/AN status (self-reported)
- age \> 18 years
- fluent in English
- a current diagnosis of T2DM.
You may not qualify if:
- a major medical issue that may interfere with participation (e.g., prior cardio- or cerebrovascular disease including a recent myocardial infarction or major stroke; cancer not in remission; dialysis; active alcohol and/or substance abuse.)
- a planned move from the area within the 3 to 6 month data collection time period that would not allow completion of all the study visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Lakeport Tribal Health Consortium
Lakeport, California, 95453, United States
Cherokee Indian Hospital
Cherokee, North Carolina, 28719, United States
Indian Health Care Resource Center of Tulsa
Tulsa, Oklahoma, 74120, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kelly R Moore, MD
University of Colorado, Denver
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2020
First Posted
February 5, 2020
Study Start
February 20, 2020
Primary Completion
December 30, 2021
Study Completion
May 31, 2022
Last Updated
January 11, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share